Gamida Cell Ltd.
GMDA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | 0.15 | -0.10 |
| FCF Yield | -130.80% | -93.25% | -64.33% | -16.47% |
| EV / EBITDA | -1.38 | -1.63 | -2.01 | -4.09 |
| Quality | ||||
| ROIC | -86.17% | 138.64% | -69.68% | -47.15% |
| Gross Margin | -94.96% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.26 | 0.89 | 0.91 | 0.67 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -4.46% | 20.70% | -60.21% | -47.45% |
| Safety | ||||
| Net Debt / EBITDA | -0.52 | -0.53 | -0.27 | 1.97 |
| Interest Coverage | -9.63 | 17.11 | -33.19 | -5.86 |
| Efficiency | ||||
| Inventory Turnover | 1.82 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 332.13 | -5,295.82 | -7,005.29 | -6,472.87 |